FUNDAMENTALS |
MarketCap: |
1.801 mill
|
EPS: |
-18.76
|
P/E: |
-0.0098
|
Earnings Date: |
Nov 17, 2022 |
SharesOutstanding: |
9.82 mill
|
Avg Daily Volume: |
1.237 mill
|
QUARTER GROWTHS |
|
1/20 | 2/20 | 2/21 | 4/21 | 2/22 | 4/22 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Ebit | n/a | n/a | n/a | n/a | n/a | n/a |
Asset | n/a | n/a | n/a | n/a | n/a | n/a |
Debt | n/a | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
0.00x
|
Company: PE -0.0098 | sector: PE -3.05
|
PE RATIO: COMPANY / INDUSTRY |
0.00x
|
Company: PE -0.0098 | industry: PE 33.06
|
DISCOUNTED CASH FLOW VALUE |
N/A
|
N/A
|
Expected Trading Range (DAY) |
$ 0.0170 - 0.103
( +/- 71.67%)
|
ATR Model: 14 days
|
Insider Trading
Date |
Person |
Action |
Amount |
type |
2023-03-31 | Awm Investment Company, Inc. | Sell | 437 500 | Common Stock |
2023-04-03 | Awm Investment Company, Inc. | Sell | 300 000 | Common Stock |
2023-03-31 | Awm Investment Company, Inc. | Buy | 0 | Common Stock |
INSIDER POWER |
-100.00
|
Last
2 transactions |
Buy:
0 | Sell:
737 500 |
Forecast:
01:40 - $0.0850
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals |
RSI 21 |
|
SMA |
|
Trend |
|
Trend 2 |
|
Trend 3 |
|
MACD |
|
Volume Signals |
Price |
$0.184 (1.38% )
|
Volume |
2.25 mill
|
Avg. Vol. |
1.237 mill
|
% of Avg. Vol |
181.69 %
|
Signal 1: |
|
Signal 2: |
|
Last 10 Buy & Sell Signals For GMVD
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.